Viewing Study NCT00327093


Ignite Creation Date: 2025-12-25 @ 1:22 AM
Ignite Modification Date: 2025-12-25 @ 11:32 PM
Study NCT ID: NCT00327093
Status: TERMINATED
Last Update Posted: 2009-02-09
First Post: 2006-05-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Elaboration of a Model for Predicting Efficacy of Monoclonal Antibodies (Cetuximab and Bevacizumab) in Patients With Colorectal Cancer and Liver Metastases
Sponsor: Hospices Civils de Lyon
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module